Outpatient therapy of serious pediatric infections with ceftriaxone.
Convalescent outpatient parenteral antibiotic therapy with ceftriaxone was evaluated in an uncontrolled study of 101 children with documented serious bacterial infections, including meningitis. Criteria for outpatient therapy were established to assure that risks of complications from the illness were minimal at the time of discharge from the hospital. Daily physician visits and motivated, capable parents were considered essential in outpatient management. Ceftriaxone was given once daily to children with non-central nervous system infections and once or twice daily intravenously to children with meningitis. The mean durations of therapy for children with non-central nervous system infections and with meningitis were 2.4 and 4.6 days, respectively. No child enrolled in this study was readmitted to the hospital for medical or social reasons. Probable complications of treatment included diarrhea in 13% of children with meningitis and in 6% of children with non-central nervous system infections. One child with meningitis developed pseudomembranous colitis. For children who are infected with bacteria that are highly susceptible to ceftriaxone, single daily dose outpatient therapy is a reasonable option for management if a good clinical response to initial treatment is demonstrated and the risks of complications of the disease process are negligible.
Bradley
J S
JS
Department of Pediatrics, Oregon Children's Medical Center, Emanuel Hospital, Portland.
Ching
D K
DK
Phillips
S E
SE
D000293:Adolescent; D000553:Ambulatory Care; D001424:Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology; D001427:Bacterial Toxins / Q000032:analysis; D001770:Blood Bactericidal Activity; D002443:Ceftriaxone / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D003015:Clostridium Infections / Q000188:drug therapy; D003967:Diarrhea / Q000139:chemically induced; D005243:Feces / Q000382:microbiology; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008581:Meningitis / Q000188:drug therapy / Q000382:microbiology; D011379:Prognosis; D011446:Prospective Studies
D001427:Bacterial Toxins; D002443:Ceftriaxone